| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $51.5M | +18.7% |
| Cost of Revenue | $26.5M | +20.8% |
| Gross Profit | $25.0M | +16.4% |
| R&D Expense | $6.7M | -4.0% |
| SG&A Expense | $11.3M | +13.7% |
| Operating Income | -$1.4M | +61.0% |
| Pre-tax Income | -$1.1M | +69.6% |
| Income Tax | $156K | -97.5% |
| Net Income | -$1.2M | +87.4% |
| EPS (Basic) | -$0.12 | +87.9% |
| EPS (Diluted) | -$0.12 | +87.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.4M | +42.0% |
| Accounts Receivable | $6.4M | -2.2% |
| Inventory | $10.9M | -32.8% |
| Current Assets | $38.8M | +1.2% |
| Total Assets | $44.8M | +1.7% |
| Current Liabilities | $13.0M | +1.3% |
| Total Liabilities | $13.7M | +1.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.7M | +312.3% |
| Capital Expenditures | $109K | -66.1% |
| Investing Cash Flow | -$1.6M | -400.6% |
| Financing Cash Flow | -$119K | -118.8% |
| Free Cash Flow | $7.6M | +391.5% |
| $31.1M |
| +1.6% |